tiprankstipranks
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
US Market

Verrica Pharmaceuticals (VRCA) Income Statement

Compare
438 Followers

Verrica Pharmaceuticals Income Statement

Last quarter (Q3 2024), Verrica Pharmaceuticals's total revenue was $-1.78M, a decrease of -161.06% from the same quarter last year. In Q3, Verrica Pharmaceuticals's net income was $-22.86M. See Verrica Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.12M$ 9.03M$ 12.00M$ 0.00$ 0.00
Gross Profit
$ 4.38M$ 8.31M$ 11.53M$ -229.00K$ -257.20K
Operating Expenses
$ 70.14M$ 29.60M$ 42.91M$ 40.18M$ 30.08M
Depreciation and Amortization
$ 836.00K$ 718.00K$ 472.00K$ 229.00K$ 257.20K
EBITDA
$ -62.20M$ -21.60M$ -30.31M$ -39.43M$ -30.08M
Operating Income
$ -65.76M$ -21.30M$ -30.91M$ -40.18M$ -30.08M
Other Income/Expenses
$ -1.24M$ -3.19M$ -4.17M$ -2.51M$ 1.87M
Pretax Income
$ -67.00M$ -24.49M$ -35.08M$ -42.69M$ -28.21M
Net Income
$ -67.00M$ -27.68M$ -38.90M$ -45.50M$ -27.95M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.48$ -0.81$ -1.44$ -1.82$ -1.12
Diluted EPS
$ -1.48$ -0.81$ -1.44$ -1.82$ -1.12
Weighted Average Shares Outstanding
45.34M 34.16M 27.04M 25.00M 24.90M
Weighted Average Shares Outstanding (Diluted)
45.34M 34.16M 27.04M 25.00M 24.90M
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis